Clinical Trial Update: Rheumatoid Arthritis Treatment After First Anti-TNF INvestiGation [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating rheumatoid arthritis treatment after first anti-TNF failed or investigated, which has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Rheumatoid Arthritis | Phase 4 | Status: TERMINATED